Pharmacy benefit management

Improve cost control by decreasing the personal impact of injuries and pacesetting analytics, clinical expertise, and operational excellence.

Learn more


Ancillary benefit management

Ensure quality with vetted providers for medical equipment, transportation, home care, language services, and more.

Learn more

Managed care

Managed care

Gain access to our PPO network service, medical bill review and case management to provide quality care that improves clinical and financial outcomes.

Learn more


Settlement solutions

Begin tracking claims from the very first fill, with best-in-class solutions that facilitate settlement, and maximize overall savings.

Learn more

Sharing our perspective

Trending content

  • Oral formulation of Relistor® approved to treat opioid-induced constipation

    • Optum for Workers' Compensation
    | Jul 21, 2016
    Tag Icon
    Opioids, FDA
    The U.S. Food and Drug Administration (FDA) has approved an oral formulation of Relistor® (methylnaltrexone bromide). The medication is indicated to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. OIC is a frequent and persistent side effect of opioid analgesic therapy linked to opioid receptors located in the gastrointestinal (GI) and central nervous systems.

    Full story

Upcoming events

Anaheim, CA
July 13-15, 2016 

FASI 47th Annual Educational Conference & Trade Show
Naples, ​FL
July 17-20, 2016

SEAK 2016 Conference
Cape Cod, MA
July 19-20, 2016